Welcome to our dedicated page for Calumet SEC filings (Ticker: CLMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Calumet, Inc. filings document operating results, governance matters and capital-structure actions for a Nasdaq-listed specialty products and renewable fuels company. The record includes Form 8-K disclosures for quarterly and annual results, Regulation FD communications, material definitive agreements, credit-agreement amendments, direct financial obligations and senior-note transactions involving subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp.
Proxy materials describe annual meeting voting matters, board elections and related governance disclosures. The filings also identify Calumet's common stock, par value $0.01 per share, under symbol CLMT on The Nasdaq Stock Market LLC and provide formal disclosure around debt terms, covenant changes, risk-related governance and shareholder matters.
Calumet, Inc. director Daniel J. Sajkowski reported an open-market sale of 4,240 shares of common stock at a weighted average price of $36.16 per share. After this transaction, he directly holds 77,718 shares, so the sale represents a relatively small portion of his position.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025, when the stock closed at $19.08 per share. The shares were sold in multiple trades at prices ranging from $35.72 to $36.33 per share.
The Heritage Group filed an amended Schedule 13D updating its ownership in Calumet, Inc. following a warrant exercise and a large share gift. The reporting person now beneficially owns 14,523,185 shares of common stock, or 16.56% of Calumet’s 87,686,561 shares outstanding as of June 2, 2026.
The Heritage Group previously received warrants to acquire 1,020,000 shares at $20.00 per share and on May 15, 2026 exercised these warrants in full, receiving 393,002 shares via net settlement and disposing of 626,998 shares back to the issuer. On June 5, 2026, it approved a gift of 540,000 directly held shares. The filing also clarifies the structure of indirect holdings and includes disclaimers of beneficial ownership by related trusts and trustees.
Heritage Group, a 10% owner of Calumet, Inc., reported a charitable gift of 540,000 shares of Common Stock. The shares were transferred as a bona fide gift at a reported price of $0.00 per share to The J.E. Fehsenfeld Family Foundation, Inc., a tax-qualified private foundation.
Following the gift, Heritage Group reports direct ownership of 12,440,211 Calumet shares. It also reports indirect beneficial ownership of 1,200,000 shares held by The Heritage Group Investment Company, LLC and 882,974 shares held by Lumet Investments, Inc., while disclaiming beneficial ownership of those indirect holdings except to the extent of any pecuniary interest.
SANDERS BRADFORD TIMOTHY reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Bradford Timothy Sanders received a grant of 3,461 Restricted Stock Units (RSUs) that are the economic equivalent of 3,461 shares of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting and will be settled in shares upon vesting.
Calumet, Inc. /DE director Bradford Timothy Sanders has filed a Form 3 ownership report for CLMT. The filing lists him as a director and shows no reported transactions, share holdings, or derivative positions in the issuer’s securities in this submission.
Raymond Paul C reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Raymond Paul C received a grant of 3,461 Restricted Stock Units on June 2, 2026. Each unit is the economic equivalent of one share of Calumet common stock.
The Restricted Stock Units vest on the earlier of June 2, 2027 or the company’s 2027 Annual Meeting, and will be settled in stock upon vesting. After this award, he holds 3,461 units directly.
Twitchell Karen A. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Karen A. Twitchell received a grant of 3,461 restricted stock units (RSUs). Each RSU is the economic equivalent of one share of Calumet common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting and will be settled upon vesting.
After this compensation-related award, Twitchell holds 3,461 RSUs directly. This is a routine equity grant to a director, not an open-market share purchase or sale.
Boss John G. reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director John G. Boss received a grant of 3,461 Restricted Stock Units (RSUs). Each RSU represents the economic equivalent of one share of Calumet common stock. Following this award, he holds 3,461 RSUs directly.
The RSUs vest upon the earlier of June 2, 2027 or the date Calumet holds its 2027 Annual Meeting, and will be settled in shares when they vest. This is a compensation-related equity award rather than an open‑market stock purchase or sale.
Quintana Julio M reported acquisition or exercise transactions in this Form 4 filing.
Calumet, Inc. director Julio M. Quintana reported an equity compensation grant of 3,461 Restricted Stock Units (RSUs), each equal to one share of common stock. The RSUs vest on the earlier of June 2, 2027 or the company’s 2027 annual meeting and are settled in shares upon vesting. Following this grant, Quintana holds 3,461 RSUs directly, with no open-market buy or sell activity disclosed.